Abstract
Varied modes of onset make the early diagnosis of Wilson's disease difficult. A deficiency of serum ceruloplasmin, usually characteristic of the disease, was used as the basis for a screening test. Simple test materials and provision for handling about 50 plasma samples simultaneously made this test feasible for large-scale screening.
The screening test was applied to 336 persons hospitalized for psychiatric disorders, to detect patients with Wilson's disease before the classical symptoms appeared. Two patients with ceruloplasmin levels below the normal limits were detected but did not have Wilson's disease. Further application of the screening test to relatives of patients known to have Wilson's disease and to individuals with any symptoms of the disease (hepatic disease, extrapyramidal dysfunction, psychiatric disorders, behaviour problems in children) would aid in early diagnosis and more effective treatment.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- AISEN P., SCHORR J. B., MORELL A. G., GOLD R. Z., SCHEINBERG I. H. A rapid screening test for deficiency of plasma ceruloplasmin and its value in the diagnosis of Wilson's disease. Am J Med. 1960 Apr;28:550–554. doi: 10.1016/0002-9343(60)90149-2. [DOI] [PubMed] [Google Scholar]
- AZIMA H., RICHMAN A. Alteration of copper metabolism in chlorpromazine-treated cases. AMA Arch Neurol Psychiatry. 1956 Feb;75(2):163–166. doi: 10.1001/archneurpsyc.1956.02330200057006. [DOI] [PubMed] [Google Scholar]
- BEARD A. W. The association of hepatolenticular degeneration with schizophrenia. A review of the literature and case report. Acta Psychiatr Scand. 1959;34:411–428. doi: 10.1111/j.1600-0447.1959.tb07531.x. [DOI] [PubMed] [Google Scholar]
- BEARN A. G. Genetic and biochemical aspects of Wilson's disease. Am J Med. 1953 Oct;15(4):442–449. doi: 10.1016/0002-9343(53)90134-x. [DOI] [PubMed] [Google Scholar]
- Cox D. W. Factors influencing serum ceruloplasmin levels in normal individuals. J Lab Clin Med. 1966 Dec;68(6):893–904. [PubMed] [Google Scholar]
- GERMAN J. L., 3rd, BEARN A. G. Effect of estrogens on copper metabolism in Wilson's disease. J Clin Invest. 1961 Mar;40:445–453. doi: 10.1172/JCI104272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- STERNLIEB I., SCHEINBERG I. H. PENICILLAMINE THERAPY FOR HEPATOLENTICULAR DEGENERATION. JAMA. 1964 Sep 7;189:748–754. doi: 10.1001/jama.1964.03070100042008. [DOI] [PubMed] [Google Scholar]
- STERNLIEB I., SCHEINBERG I. H. The diagnosis of Wilson's disease in asymptomatic patients. JAMA. 1963 Mar 2;183:747–750. doi: 10.1001/jama.1963.03700090067011. [DOI] [PubMed] [Google Scholar]